HomeCINPHA • STO
add
Cinclus Pharma Holding publ AB
Previous close
kr 15.00
Day range
kr 15.00 - kr 16.44
Year range
kr 9.31 - kr 40.00
Avg Volume
182.58K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 47.52M | 31.00% |
Net income | -33.67M | 8.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -47.07M | -31.01% |
Effective tax rate | -0.22% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 523.90M | 898.51% |
Total assets | 555.43M | 858.21% |
Total liabilities | 43.81M | -74.75% |
Total equity | 511.62M | — |
Shares outstanding | 46.54M | — |
Price to book | 1.36 | — |
Return on assets | -20.55% | — |
Return on capital | -22.25% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -33.67M | 8.74% |
Cash from operations | -41.79M | -17.74% |
Cash from investing | — | — |
Cash from financing | -340.00K | -3.98% |
Net change in cash | -42.82M | -20.60% |
Free cash flow | -27.44M | 7.23% |
About
Founded
2014
Website
Employees
19
